Product warning issued for weight loss drug Belvic: FDA
Taipei, Feb. 14 (CNA) Taiwan's Food and Drug Administration (FDA) on Friday issued a product warning for the weight loss drug Belviq, after American medical authorities reported on Thursday that clinical trials on the drug's active ingredient, lorcaserin, showed an increased risk of several types of cancer.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Trace levels of radiation found in mushroom powder imported from Japan12/05/2023 03:21 PM
Taiwan shares close down 0.54%12/05/2023 02:34 PM
Taiwan opens 4th representative office in Canada12/05/2023 02:25 PM
Chinese snack prompts concerns over young students' health, nutrition12/05/2023 02:01 PM
Two new Chinese satellites no danger to Taiwan: Defense ministry12/05/2023 01:04 PM